The ground seems to be ready for a defense for humans against the coronavirus pandemic. Moderna Inc.’s vaccine candidate protected 16 monkeys in a trial. Its result in 30,000 humans is awaited, reported livemint.
Two injections of the vaccine protected against heavy exposure to the virus at two different levels of dosage, Moderna said in findings published on Tuesday in the New England Journal of Medicine, reported livemint.
The results on primates
The results, if they hold up in humans, suggest that the vaccine may be able to protect against Covid-19 in both the upper and lower airways, reported livemint quoting the study.
Phase 3 trial to determine the safety and efficacy of the vaccine will begin producing data in November or December. The U.S. government is providing $955 million to help fund the vaccine’s development.
Moderna Inc is planning to price its coronavirus vaccine at $50 to $60 per course, which is $11 more than another vaccine from Pfizer Inc and BioNTech, livemint quoted Financial Times as reporting on Tuesday, citing unnamed sources.
Bhubaneswar: Odisha Chief Minister Mohan Charan Majhi led the state in celebrating Constitution Day on…
Mumbai: Amid suspense over who would head the next Mahayuti government in Maharashtra, Shiv Sena…
Jajpur: A motorcyclist died and a female cop sustained injuries as a gas tanker rammed…
Bhubaneswar: The Odisha Legislative Assembly is set to begin its winter session on Tuesday, on…
Mumbai: After beau Arjun Kapoor declared publicly that he is not dating anyone right now,…
Mumbai: Even though Aishwarya Rai and Abhishek Bachchan have maintained a dignified silence over their…
Bhubaneswar: Siddhant Das has sought to step down as Chairman of Odisha Real Estate Regulatory…
Hyderabad: Odisha FC went on a scoring spree at the Gachibowli Stadium as they humbled hosts…